Amgen reviews

This once great company has been decimated and the staff demoralized by the greedy senior management which has wasted tens of billions of dollars on share buybacks to appease Wall Street and large shareholders. This money would have been better spent on more astute funding of research and superior scientific leaders. The main reason for the share buybacks is to maintain their EPS even though their revenues have been declining for the past few years. In addition, the decimation of the Cambridge site(Neuroscience, HTS, PKDM, Chemistry, and Toxicology) is an abomination and a perfect example of the treachery/greed/shortsightedness of the corrupt bourgeoisie of Thousand Oaks, CA.

The culture here was toxic, and even after 10 years I was constantly defending myself despite high ratings and pushing the ball forward. You’re forced to perform to a moving target and there’s so much closed-door evaluating going on that you can’t improve or progress through the the ranks without a significant amount of game-playing. Most of medical affairs has moved on to better companies and left the black hole of career suicide that Amgen has become, me included.